ProKidney (NASDAQ: PROK) net income
ProKidney reported a net loss of $69.0m for fiscal 2025; in fiscal 2024 it reported a net loss of $61.2m.
ProKidney's best year of the last 5 was fiscal 2023. It reported a loss in 5 of those 5 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$69.0m | — | −7,725.2% | — |
| 2024 | −$61.2m | — | −80,507.9% | — |
| 2023 | −$35.5m | — | — | — |
| 2022 | −$148.1m | — | — | −$0.23 |
| 2021 | −$55.1m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
ProKidney net income compared with its sector
By net income for its latest fiscal year, ProKidney ranks 293rd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of ProKidney, −7,725.2%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 291st | OraSure Technologies | −$68.7m | −59.8% |
| 292nd | Liquidia | −$68.9m | −43.5% |
| 293rd | ProKidney | −$69.0m | −7,725.2% |
| 294th | Senseonics | −$69.1m | −196.0% |
| 295th | Design Therapeutics | −$69.8m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of ProKidney
- How much did ProKidney earn in fiscal 2025?
- ProKidney reported a net loss of $69.0m for fiscal 2025. In fiscal 2024 it reported a net loss of $61.2m.
- Where does ProKidney rank in its sector by net income?
- It ranks 293rd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for ProKidney come from?
- From the annual report (Form 10-K) that ProKidney files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that ProKidney files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021. More on ProKidney: the ProKidney page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.